TI
BBNX

Trexquant Investment’s Beta Bionics BBNX Stock Holding History

Trexquant Investment’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.75M Buy
494,435
+252,834
+105% +$3.01M 0.05% 544
2026
Q1 		$2.42M Buy
241,601
+125,840
+109% +$1.86M 0.02% 922
2025
Q4 		$3.53M Buy
+115,761
New +$3.09M 0.03% 754

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Trexquant Investment's BBNX Position: Q2 2026 in Review

Trexquant Investment increased its Beta Bionics (BBNX) stake by 105% in Q2 2026, buying an estimated $3.01M and bringing the position to 494,435 shares worth $7.75M. The position accounts for 0.05% of the portfolio, ranked #544.

Trexquant Investment first reported a position in BBNX in Q4 2025 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Trexquant Investment held 494,435 shares of Beta Bionics worth $7.75M as of Q2 2026.
  • Trexquant Investment bought 252,834 Beta Bionics shares in Q2 2026, an estimated $3.01M.
  • Beta Bionics made up 0.05% of Trexquant Investment's portfolio in Q2 2026, its #544 holding.
  • Trexquant Investment first reported a position in Beta Bionics in Q4 2025 and has held it in 3 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.